Condition: Arrhythmia · Sponsor: QuesGen Systems Inc
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
This description comes directly from the study's public registry record.
Michael Jarrett, MBA · 415-608-3570 · mike.jarrett@quesgen.com
Martin Jorgensen, PhD · 650-777-7617 · martin.jorgensen@quesgen.com
Always discuss trial participation with your own doctor first.
| Cardio Surgical Partners, LLC | Lehi, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03604133